3rd World ADC Asia 2024
Evvnt Promotion / evvnt
25.06.2024 - 27.06.2024 Grand Hyatt Incheon, 208 Yeongjonghaeannam-ro 321beon-gil, 22382 Jung-gu, Incheon, South Corea
Time: 8:00 am to 5:15 pm
Temi della conferenza
The year 2024 has been considered the 'coming of age' era for antibody-drug conjugates, in great part due to the remarkable resurgence in drug development across the Asia-Pacific region. This part of the world is taking the ADC industry by storm with high-profile deals, multiple approvals, multiple ADCs moving into clinical trials, and novel targets being explored just to name some advancements.
The year 2024 has been considered the 'coming of age' era for antibody-drug conjugates, in great part due to the remarkable resurgence in drug development across the Asia-Pacific region. This part of the world is taking the ADC industry by storm with high-profile deals, multiple approvals, multiple ADCs moving into clinical trials, and novel targets being explored just to name some advancements.
Scientific organizer
Hanson Wade
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/2191904-3?pid=4832
Speakers: Dohyun Nam, Chairman, Professor, Aimed Bio Inc., Jinwon Jung, Senior Directory, ABL Bio, Jia He, Senior Research Analyst Targeted Therapies, Beacon and More.
Brochure: https://go.evvnt.com/2191904-3?pid=4832
Speakers: Dohyun Nam, Chairman, Professor, Aimed Bio Inc., Jinwon Jung, Senior Directory, ABL Bio, Jia He, Senior Research Analyst Targeted Therapies, Beacon and More.
Informazioni ed Iscrizioni:
https://go.evvnt.com/2191904-2?pid=4832
Ms. Jessica Durston
Oncologia
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
